Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.89 |
| ▸ | CA4 | P22748 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | MMP12 | P39900 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL27628723 | 1.00 | CA1 (0.89) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL23872 | 1.00 | — | — | |
| Acetic Acid SCHEMBL2407889 | 1.00 | CA1 (0.89) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL11588982 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL10422345 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL23924735 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL17584783 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL80426 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL1986019 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL10955029 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2845896-B1 | A process of using a consumer product for treating fabric | PROCTER & GAMBLE (US) | 2025-03-26 | — | — | EP | disclosed |
| CN-119528186-A | Preparation process of high-purity active magnesium oxide | 濮阳濮耐高温材料（集团）股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-12129454-B2 | Laundry detergent sheet with microcapsules | THE PROCTER & GAMBLE COMPANY (US) | 2024-10-29 | — | — | US | disclosed |
| US-20230272312-A1 | LAUNDRY DETERGENT SHEET WITH MICROCAPSULES | PROCTER & GAMBLE (US) | 2023-08-31 | — | — | US | disclosed |
| US-11680232-B2 | Laundry detergent sheet with microcapsules | THE PROCTER & GAMBLE COMPANY (US) | 2023-06-20 | — | — | US | disclosed |
| EP-2313058-B1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2022-09-28 | — | — | EP | disclosed |
| CN-112552099-B | Nitrophosphate fertilizer and preparation method thereof | 贵州芭田生态工程有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-112552099-A | Nitrophosphate fertilizer and preparation method thereof | 贵州芭田生态工程有限公司 | 2021-03-26 | — | — | CN | disclosed |
| US-20210040420-A1 | LAUNDRY DETERGENT SHEET WITH MICROCAPSULES | PROCTER & GAMBLE (US) | 2021-02-11 | — | — | US | disclosed |
| CN-108249806-B | A kind of preparation method of hydrated calcium silicate early strength agent and a kind of self-compacting concrete | 镇江建科建设科技有限公司 | 2019-10-01 | — | — | CN | disclosed |
| US-20070275870-A1 | incorporating friable perfume microcapsules into dryer-added articles that maximizes the yield of unruptured microcapsules; consumers have freshness experience while wearing clothing treated therewith | PROCTER & GAMBLE COMPANY, THE | 2007-11-29 | — | — | US | disclosed |
| WO-2007135638-A1 | PROCESS OF INCORPORATING MICROCAPSULES INTO DRYER-ADDED FABRIC CARE ARTICLES | THE PROCTER & GAMBLE COMPANY (US) | 2007-11-29 | — | — | WO | disclosed |
| WO-2007100501-A2 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | APPLETON PAPERS INC. (US) | 2007-09-07 | — | — | WO | disclosed |
| WO-2007099469-A2 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2007-09-07 | — | — | WO | disclosed |
| US-20070202063-A1 | Benefit agent containing delivery particle | PROCTER & GAMBLE COMPANY, THE | 2007-08-30 | — | — | US | disclosed |
| CN-1035869-C | Method for prepn. of ball shaped hydroxy-apatite with homogeneous precipitation | INST OF CHEMICAL METALLURG CAS (CN) | 1997-09-17 | — | — | CN | disclosed |
| US-5451403-A | Antiinflammatory agents and enzyme inhibitors for animals | ELI LILLY AND COMPANY (US) | 1995-09-19 | — | — | US | disclosed |
| US-5350579-A | Culture of Amycolatopsis | ELI LILLY AND COMPANY (US) | 1994-09-27 | — | — | US | disclosed |
| US-5278064-A | Culture of microorganisms and mutants | ELI LILLY AND COMPANY (US) | 1994-01-11 | — | — | US | disclosed |
| EP-0526258-A2 | A87689 Compounds, their production and use as phospholipase-A2 inhibitors | ELI LILLY AND COMPANY (US) | 1993-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070202063-A1 | Benefit agent containing delivery particle | APOB, CHMP4B, HDLBP | CA1 3539/4885CA4 2997/4885LMNA 1230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.